v3.26.1
Schedule of Fair Value Assets Measured on Recurring Basis (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
PIPE Warrants [Member]        
Impairment Effects on Earnings Per Share [Line Items]        
Balance, January 1, 2025 $ 280 $ 79,512 $ 79,512 $ 273,124
Fair value adjustment (231) (71,918) (79,232) (193,612)
Exchanged for Common Stock      
Exchanged for Series B Convertible Preferred Stock and Series B Warrants      
Balance, March 31, 2025 49 7,594 280 79,512
Abaca Warrant [Member]        
Impairment Effects on Earnings Per Share [Line Items]        
Balance, January 1, 2025 28,430 1,024,900 1,024,900 3,384,085
Fair value adjustment (14,919) (795,652) (996,470) (2,359,185)
Exchanged for Common Stock      
Exchanged for Series B Convertible Preferred Stock and Series B Warrants      
Balance, March 31, 2025 13,511 229,248 28,430 1,024,900
Private Placement Warrants [Member]        
Impairment Effects on Earnings Per Share [Line Items]        
Balance, January 1, 2025 14 9,632 9,632 25,070
Fair value adjustment (12) (9,110) (9,618) (15,438)
Exchanged for Common Stock      
Exchanged for Series B Convertible Preferred Stock and Series B Warrants      
Balance, March 31, 2025 2 522 14 9,632
Third Anniversary Payment Consideration [Member]        
Impairment Effects on Earnings Per Share [Line Items]        
Balance, January 1, 2025 322,000 322,000 810,000
Fair value adjustment   (161,000) (63,133) (488,000)
Exchanged for Common Stock     258,867  
Exchanged for Series B Convertible Preferred Stock and Series B Warrants      
Balance, March 31, 2025   161,000 322,000
Forward Purchase Derivative [Member]        
Impairment Effects on Earnings Per Share [Line Items]        
Balance, January 1, 2025 7,309,580 7,309,580 7,309,580
Fair value adjustment  
Exchanged for Common Stock      
Exchanged for Series B Convertible Preferred Stock and Series B Warrants     (7,309,580)  
Balance, March 31, 2025   $ 7,309,580 $ 7,309,580